Capstone Therapeutics Corp
Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capsto… Read more
Capstone Therapeutics Corp (CAPS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: -1.191x
Based on the latest financial reports, Capstone Therapeutics Corp (CAPS) has a cash flow conversion efficiency ratio of -1.191x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.29 Million) by net assets ($-1.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Capstone Therapeutics Corp - Cash Flow Conversion Efficiency Trend (2014–2023)
This chart illustrates how Capstone Therapeutics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Capstone Therapeutics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Capstone Therapeutics Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Success Hldg Grp
PINK:SHGR
|
N/A |
|
Diesel & Motor Engineering PLC
CM:DIMON0000
|
N/A |
|
Damaris SA
PA:MLDAM
|
N/A |
|
SHINKO PLANTECH
BE:S2O
|
N/A |
|
VIA optronics AG
PINK:VIAOY
|
N/A |
|
Jeisys Medical Inc.
KO:287410
|
N/A |
|
AUTO HALL
BC:AUTO-HALL
|
N/A |
|
Manulife Canadian Equity Class
TO:MCAN
|
N/A |
Annual Cash Flow Conversion Efficiency for Capstone Therapeutics Corp (2014–2023)
The table below shows the annual cash flow conversion efficiency of Capstone Therapeutics Corp from 2014 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $2.44 Million | $1.45 Million | 0.595x | +268.13% |
| 2022-12-31 | $8.17 Million | $-2.89 Million | -0.354x | -159.27% |
| 2021-12-31 | $6.24 Million | $3.72 Million | 0.597x | +439.82% |
| 2020-12-31 | $5.81 Million | $642.00K | 0.111x | -74.05% |
| 2019-12-31 | $-3.94 Million | $-1.68 Million | 0.426x | +902.81% |
| 2018-12-31 | $-1.24 Million | $66.00K | -0.053x | -102.99% |
| 2017-12-31 | $-879.00K | $-1.56 Million | 1.776x | -82.79% |
| 2016-12-31 | $-122.00K | $-1.26 Million | 10.320x | +342.53% |
| 2015-12-31 | $506.00K | $-2.15 Million | -4.255x | -222.50% |
| 2014-12-31 | $3.10 Million | $-4.09 Million | -1.319x | -- |